| 000 | 04130nam a22004095i 4500 | ||
|---|---|---|---|
| 999 |
_c11310 _d11310 |
||
| 001 | 11310 | ||
| 003 | DE-He213 | ||
| 005 | 20210706040347.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 180618s2018 gw | s |||| 0|eng d | ||
| 020 | _a9783319776743 | ||
| 024 | 7 |
_a10.1007/978-3-319-77674-3 _2doi |
|
| 040 |
_aES-MaUEC _bspa _dES-VaUE |
||
| 050 | 4 |
_aRC582 _b.M36 2018 EB |
|
| 245 | 1 | 0 |
_aManagement of Infections in the Immunocompromised Host _cedited by Brahm H. Segal. |
| 264 | 1 |
_aCham _bSpringer International Publishing : _bImprint: Springer _c2018. |
|
| 300 | _a1 recurso en línea (XIV, 445 páginas 27 ilustraciones a color) | ||
| 336 |
_2rdacontent _aTexto (visual) _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 | _aMedicine (Springer-11650) | |
| 505 | 0 | _a1.Phagocytes -- 2.T-cells -- 3.B cell Immunity -- 4.Complement -- 5.Antimicrobial peptides -- 6.Role of Deficits in Pathogen Recognition Receptors in Infection Susceptibility -- 7.Defects of Innate Immunity -- 8.T Cell Defects -- 9.Inflammatory Bowel Disease in Primary Immunodeficiencies -- 10.Infections in Cancer -- 11.Infections in Hematopoietic Stem Cell Transplant Recipients -- 12.Infections in Solid Organ Transplant Recipients -- 13.Infections in HIV infected patients -- 14.Infections in Patients with Autoimmune Diseases -- 15.Antibacterials and antifungals: The Challenges of Antibiotic-Resistant Infections in the Immunocompromised Host -- 16.Antiviral treatment and prophylaxis in immunocompromised hosts -- 17.Role of Immunoglobulin Therapy to Prevent and Treat Infections -- 18.Vaccination of Immunocompromised Patients -- 19..Stem Cell Transplantation for Primary Immunodeficiency -- 20.Specific Adoptive T-cell Therapy for Viral and Fungal Infections -- 21.Gene Therapy for Primary Immunodeficiencies. | |
| 520 | 3 | _aThis book provides a comprehensive, state-of-the-art review of the concepts vital to a modern treatment of common and opportunistic infections in the immunocompromised host. Chapters are written by experts in the field, and include their views on gaps in the field and future directions of research. This book begins with an overview of the normally functioning immune system followed by a detailed discussion of the major primary immunodeficiencies. Specific chapters are dedicated to providing practical knowledge in the prevention and treatment of infections in specific immunocompromised patients, including those with cancer, transplant recipients, HIV infection, and autoimmune disorders. Emphasis is placed on diagnostic evaluation, antimicrobial selection that includes consideration of the threat of antimicrobial-resistant pathogens, and immunotherapy tailored to specific patients. Finally, dedicated chapters on stem cell transplantation for patients with primary immunodeficiencies, adoptive cellular immunotherapy, and gene therapy will provide readers with insight into these rapidly evolving and cutting edge therapies. Management of Infections in the Immunocompromised Host is a valuable resource for infectious diseases specialists, immunologists, oncologists, hematologists, general physicians, students, researchers, and all other working with immunocompromised patients. | |
| 988 | _aEBSPRINGER_2018 | ||
| 650 | 7 |
_aEnfermedades inmunológicas _9142010 _2embne |
|
| 650 | 7 |
_aOncología _9139207 _2embne |
|
| 650 | 7 |
_aInmunodeficiencia _9667061 _2embne |
|
| 700 | 1 |
_aSegal, Brahm H. _eeditor literario _0http://id.loc.gov/authorities/names/n2012180412 _0http://viaf.org/viaf/224461940 |
|
| 710 | 2 |
_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996 |
|
| 776 | 0 | 8 |
_iEdición impresa: _z9783319776729 |
| 776 | 0 | 8 |
_iEdición impresa: _z9783319776736 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-77674-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia) |
| 942 |
_2lcc _cLE |
||
| 998 |
_db _feng _ggw _h0 |
||